The Latest Breaking News from Invitae Corp

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2022

Upgrades

Benzinga · Jul 19, 2022

FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis

The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was healthy. FDA issues warning on possible false results from noninvasive prenatal screening tests. The agency noted that these tests, also known as…

Benzinga · Apr 20, 2022

Invitae Shares Fall As Q4 Earnings Fall Short Of Street Expectation

Invitae Corp's (NASDAQ: NVTA) 

Benzinga · Feb 25, 2022